Aptose Reports Results for the Third Quarter 2024

Aptose and Hanmi Pharmaceutical Co-developing Triplet Therapy of Tuspetinib with Azacitidine and Venetoclax for Newly Diagnosed AML Read More

Ads Links by Easy Branches
Play online games for free at games.easybranches.com

Guest Post Services www.easybranches.com/contribute
Arizona regulators fine natural gas utility $2 million over defective piping
The Keg Royalties Income Fund announces November 2024 cash distribution

Euro Sun Closes First Tranche of Previously Announced Private Placement Financing
ThreeD Capital Inc. Issues Early Warning Report in Connection with the Acquisition of Securities of AI/ML Innovations Inc.